Press releases

31 August, 2011

Swedish University Hospital improves monitoring of treatment efficacy in multiple sclerosis with Synthetic MRI innovation

19 May, 2011

Accelerator: First patient included in clinical study with Skruvcoat

9 May, 2011

SyntheticMR granted US patent

24 June, 2010

PledPharma reports positive results from cancer study

26 April, 2010

SyntheticMR sells first software to Bern

11 March, 2010

Accelerator recruits key personnel

13 January, 2010

PledPharma, Linköping University and Ryhov County Hospital receive research grant to the ongoing phase II clinical trial in patients with acute myocardial infarction

14 December, 2009

PledPharma AB has started a clinical phase II study in patients with acute myocardial infarction

13 August, 2009

PledPharma receives approval to conduct a clinical phase II study in patients with Acute Myocardial Infarction

16 April, 2009

Dr. Marcel Warntjes, CEO of SyntheticMR, has been granted 400 000 SEK

---

« Äldre pressmeddelanden

Nyare pressmeddelanden »

Subscribe to new press releases